Collection 會議論文/會議摘要 [14/17] 期刊論文 [52/54] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:12(16.90%) 含全文筆數:66(92.96%) 文件下載次數統計 下載大於0次:66(100.00%) 下載大於100次:62(93.94%) 檔案下載總次數:26814(0.50%) 最後更新時間: 2024-11-28 13:52 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Survival of advanced/recurrent gast... A phase 1 study of biweekly nab-pac... Analysis of mutation profiles in ex... Germline mutations of homologous re... Risk of type 2 diabetes mellitus an... Imatinib use for gastrointestinal s... PTEN regulates invasiveness in panc... Multi-kinase inhibitors for the tre... Improved survival with neoadjuvant ... Mitochondrial phosphoenolpyruvate c...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 71. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-10	A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study	Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-07-11	Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study	BMC Cancer. 2024 Jul 11;24:Article number 828.
2024-04-27	Analysis of mutation profiles in extranodal NK/T-cell lymphoma: Clinical and prognostic correlations	Annals of Hematology. 2024 Apr 27;Article in Press.
2024-02-13	Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan	Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2023-10	Risk of type 2 diabetes mellitus and hyperlipidemia in patients with chronic myeloid leukemia initiating tyrosine kinase inhibitors: A nationwide cohort study	Pharmacoepidemiology and Drug Safety. 2023 Oct;32(Suppl. S1):575.
2023-01	Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway	Cancer Medicine. 2023 Jan;12(2):1588-1601.
2022-12-28	Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan	Scientific Reports. 2022 Dec 28;12:Article number 22492.
2022-11-06	PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation	Journal of Biomedical Science. 2022 Nov 06;29:Article number 92.
2022-09	Multi-kinase inhibitors for the treatment of asymptomatic radioactive Iodine-refractory differentiated thyroid cancer: Global non-interventional study (RIFTOS MKI)	Thyroid. 2022 Sep;32(9):1059-1068.
2022-07	Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience	Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-05-15	Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience	American Journal of Cancer Research. 2022 May 15;12(5):2189-2202.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-11-30	Survival outcomes of management in metastatic gastric adenocarcinoma patients	Scientific Reports. 2021 Nov 30;11:Article number 23142.
2021-11-12	The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience	Frontiers in Oncology. 2021 Nov 12;11:Article number 741096.
2021-09	Anaplastic thyroid cancer successfully treated with radiation and immunotherapy: A case report	AACE Clinical Case Reports. 2021 Sep;7(5):299-302.
2021-07-20	Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: A nationwide population-based study	European Journal of Preventive Cardiology. 2021 Jul 20;29(9):1312-1321.
2021-07-15	No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol	Scientific Reports. 2021 Jul 15;11:Article number 14567.
2021-05	Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of acute myeloid leukemia	Cancer Medicine. 2021 May;10(9):2946-2955.
2021-04-12	An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan	Scientific Reports. 2021 Apr 12;11:Article number 7881.
2021-04	Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors	Oncologist. 2021 Apr;26(4):e567-e579.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-03	Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-kappa B/IL-6/ROS signaling	Journal of Experimental and Clinical Cancer Research. 2021 Mar;40:Article number 95.
2021-02	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling	Cancer Science. 2021 Feb;112(Suppl. 1):776.
2021-01	Experience of sorafenib treatment in differentiated thyroid cancer from Taiwan	Journal of the Formosan Medical Association. 2021 Jan;120(1,Pt 1):189-195.
2021-01	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2021 Jan;112(1):243-253.

顯示項目1-25 / 71. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目